Mr. Ed Torres has worked for more than 30 years in mid-size private and public companies. He worked 19 years as Managing Partner of Lilly Ventures, where he was a co-founder and led a team that returned 4x on invested capital.

He has led the investments in, and on the Board of successful Lilly Venture exists including: Receptos (acquired by Biogen), Coherus (NASDAQ:CHRS), Viamet (acquired by NovaQuest Capital), Conforma (acquired by BiogenIDEC), and Serenex (acquired by Pfizer). He has also been Member of Compensation Committees and/or  Audit Committees for all portfolio companies.